Results 201 to 210 of about 74,972 (273)

Constitutional <i>BRCA1</i> Promoter Methylation in Patients With Ovarian Cancer: Results of the Observational AGO-TR1 Study. [PDF]

JCO Precis Oncol
Kayali M, Hahnen E, Burges A, Reuss A, Caro-Valenzuela J, de Gregorio N, Heitz F, Schmidt S, Marmé F, Hilpert F, Wimberger P, Kommoss S, Prieske K, Engel C, Buderath P, Dietrich D, Schmutzler R, Sehouli J, Rhiem K, Harter P, Hauke J.   +20 more
europepmc   +1 more source

Co-Pathogenic Role of BRCA1 and OBSCN Deletions in Chinese Familial Breast Cancer: A Case Report. [PDF]

Am J Case Rep
Yi L, Chen K, Wang D, Wang R, Zhu X, Chai J, Jia X, Xu F, Gu M, Cui C, Zhang W.   +10 more
europepmc   +1 more source

Impaired glucose tolerance in women with BRCA1 versus BRCA2 pathogenic or likely pathogenic variants: Results from a prospective cohort study. [PDF]

Fam Cancer
Grandi G, Piombino C, Sighinolfi G, Barbieri E, Venturelli M, Melotti C, Lippi Bruni R, Grisendi V, Cuoghi Costantini R, Grippa M, Zattarin E, Tenedini E, Razzaboni E, Brigante G, D'Amico R, Nanni B, Menozzi R, Cortesi L, Dominici M, La Marca A, Toss A.   +20 more
europepmc   +1 more source

Clinicopathologic characteristics of early-onset breast cancer among unselected young Black women. [PDF]

Cancer
Beasley HK, Shah T, Tinker RJ, Weidner A, Venton L, Hu C, Roberson ML, Lehmann BD, Couch FJ, Reid S, Metcalfe K, Pal T.   +11 more
europepmc   +1 more source

Prevalence of recurrent and non-recurrent BRCA1 and BRCA2 pathogenic variants in Polish breast cancer patients: insights from a regional genetic testing cohort from Lower Silesia. [PDF]

BMC Cancer
Matkowski R, Abrahamowska M, Michalowska D, Chrusciel A, Szelachowska J, Blomka D, Lawicka P, Czykalko E, Pietron A, Ekiert M, Doraczynska-Kowalik A, Janus-Szymanska G, Kasprzak P, Szynglarewicz B, Laczmanska I.   +14 more
europepmc   +1 more source

Opportunistic Screening of High-Risk Breast Cancer Variants in Hospital Biobank Setting. [PDF]

Cancer Epidemiol Biomarkers Prev
Pehrsson M, Jakkula E, Ala-Kulju K, Loukola A, Niemelä J, Löfman K, Anttonen AK, Meretoja T, Mattson J, Lappalainen M, Pöyhönen M, Carpén O.   +11 more
europepmc   +1 more source

Comprehensive <i>BRCA1/2</i> mutation landscape in prostate cancer in the UAE and Arab population. [PDF]

Front Cell Dev Biol
Al Shareef ZM, Al-Shahrabi RM, Bhamidimarri PM, Yener B, Bouzid A, Hamad AM, Murad S, Elbarkouky A, Saheb Sharif-Askari F, Bendardaf R, Hamoudi RA, Hachim MY.   +11 more
europepmc   +1 more source

<i>LincRNA-BC7</i> as a Modulator of Olaparib Sensitivity in Triple-Negative Breast Cancer. [PDF]

Epigenomes
Fadebi OO, Alabi BA, Khanyile R, Dlamini Z, Marima R.   +4 more
europepmc   +1 more source

Exploring alternatives to tumor tissue for BRCA1/2 next-generation sequencing testing in high-grade serous ovarian cancer: A 34-case series of malignant ascites. [PDF]

Cancer Cytopathol
Pighi C, Settanni G, Angelini M, Bortesi L, Viassolo V, Ceccaroni M, Bruni F, Gori S, Zannoni GF, Pesci A.   +9 more
europepmc   +1 more source

Prevalence and clinical significance of germline pathogenic variants identified by multigene panel testing in high-risk Japanese patients with breast cancer. [PDF]

Breast Cancer
Kano M, Taruno K, Inuzuka M, Makino R, Takeuchi M, Suzuki M, Kida K, Takei J, Nagayama A, Hayashida T, Haruyama Y, Ueno T, Watanabe C, Kojima Y, Sasai R, Endo M, Momozawa Y, Nakamura S.   +17 more
europepmc   +1 more source